Clinical Trial Packaging Market Research Report by Packaging Type, Material Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19- Product Image

Sale

Clinical Trial Packaging Market Research Report by Packaging Type, Material Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Report
254 Pages
October 2022
Region: Global
360iResearch™
ID: 4989665

UP TO €1987EUR$1,990USD£1,708GBP OFF until Dec 31^st 2022

The Global Clinical Trial Packaging Market size was estimated at USD 1,083.63 million in 2021, USD 1,169.76 million in 2022, and is projected to grow at a CAGR of 8.12% to reach USD 1,731.60 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trial Packaging to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Packaging Type, the market was studied across Bags and Pouches, Blisters, Bottles, Kits or Packs, Sachets, Syringes, Tubes, and Vials and Ampoules.
Based on Material Type, the market was studied across Corrugated Fiber, Glass, Metal, Paper, and Plastic.
Based on End User, the market was studied across Clinical Research Organization, Drug Manufacturing Facilities, and Research Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trial Packaging market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Packaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Packaging Market, including Almac Group Limited, Bilcare Limited, Corden Pharma Gmbh, Fisher Clinical Services, Parexel International Corporation, Piramal Enterprises Ltd, Sharp Clinical Services, Inc, The Coghlan Group, Westrock Company, and Xerimis Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trial Packaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Packaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Packaging Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trial Packaging Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Packaging Market?
6. What is the market share of the leading vendors in the Global Clinical Trial Packaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Packaging Market?

Frequently Asked Questions about the Global Clinical Trial Packaging Market

What is the estimated value of the Global Clinical Trial Packaging Market?

The Global Clinical Trial Packaging Market was estimated to be valued at $1083.63 Million in 2021.

What is the growth rate of the Global Clinical Trial Packaging Market?

The growth rate of the Global Clinical Trial Packaging Market is 8.1%, with an estimated value of $1731.6 Million by 2027.

What is the forecasted size of the Global Clinical Trial Packaging Market?

The Global Clinical Trial Packaging Market is estimated to be worth $1731.6 Million by 2027.

Who are the key companies in the Global Clinical Trial Packaging Market?

Key companies in the Global Clinical Trial Packaging Market include Almac Group Limited, Bilcare Limited, Corden Pharma Gmbh, Fisher Clinical Services, Parexel International Corporation, Piramal Enterprises Ltd, Sharp Clinical Services, Inc, The Coghlan Group and Xerimis Inc.

Report Attribute	Details
No. of Pages	254
Published	October 2022
Forecast Period	2021 - 2027
Estimated Market Value ( USD ) in 2021	USD 1083.63 Million
Forecasted Market Value ( USD ) by 2027	USD 1731.6 Million
Compound Annual Growth Rate	8.1%
Regions Covered	Global

FIGURE 1. GLOBAL CLINICAL TRIAL PACKAGING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL CLINICAL TRIAL PACKAGING MARKET DYNAMICS
FIGURE 11. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY PACKAGING TYPE, 2027
FIGURE 14. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAGS AND POUCHES, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BLISTERS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY KITS OR PACKS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SACHETS, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGES, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TUBES, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIALS AND AMPOULES, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2021 VS 2027 (%)
FIGURE 23. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY MATERIAL TYPE, 2027
FIGURE 25. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CORRUGATED FIBER, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY GLASS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY METAL, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PAPER, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 31. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 33. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DRUG MANUFACTURING FACILITIES, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 36. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 39. AMERICAS CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 40. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 46. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 48. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 51. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 52. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 68. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. GLOBAL CLINICAL TRIAL PACKAGING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 90. GLOBAL CLINICAL TRIAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 91. GLOBAL CLINICAL TRIAL PACKAGING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021